Pharmaceutical preparations, namely, oligonucleotides, siRNA and antisense RNA for use in the treatment of cancer, hepatitis, neurodegenerative diseases, neurological diseases, hemophilia, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, rare bleeding disorders, iron overload disorders, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, chronic liver infection, anemia, myeloproliferative disorders, auto-immune disorders, chronic kidney diseases, obesity, type 2 diabetes, metabolic syndrome and related conditions, thrombocythemia, gout

'2':64 'anemia':52 'antisens':7 'auto':56 'auto-immun':55 'bleed':38 'cancer':15 'cardio':31 'cardio-metabol':30 'chronic':49,59 'complement':23 'complement-medi':22 'condit':70 'diabet':65 'diseas':18,20,25,29,33,36,61 'disord':39,42,54,58 'genet':28 'gout':72 'hemophilia':21 'hepat':16,34 'hypercholesterolemia':26 'hyperlipidemia':45 'hypertens':47 'hypertriglyceridemia':43,46 'immun':57 'infect':51 'infecti':35 'iron':40 'kidney':60 'liver':50 'mediat':24 'metabol':32,66 'mix':44 'myeloprolif':53 'name':3 'neurodegen':17 'neurolog':19 'obes':62 'oligonucleotid':4 'overload':41 'pharmaceut':1 'preeclampsia':48 'prepar':2 'rare':27,37 'relat':69 'rna':8 'sirna':5 'syndrom':67 'thrombocythemia':71 'treatment':13 'type':63 'use':10

DEXOLIGO

Owners

Goods & Services